Profarma Distribuidora de Produtos Farmacêuticos S.A (SA:PFRM3) — Market Cap & Net Worth
Market Cap & Net Worth: Profarma Distribuidora de Produtos Farmacêuticos S.A (PFRM3)
Profarma Distribuidora de Produtos Farmacêuticos S.A (SA:PFRM3) has a market capitalization of $170.57 Million (R$869.31 Million) as of August 6, 2026. Listed on the SA stock exchange, this Brazil-based company holds position #17187 globally and #161 in its home market, demonstrating a 13.44% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Profarma Distribuidora de Produtos Farmacêuticos S.A's stock price R$7.09 by its total outstanding shares 122610573 (122.61 Million). See how much does Profarma Distribuidora de Produtos Farma reinvest in capital to understand how much of operating cash flow is reinvested back into capital assets.
Profarma Distribuidora de Produtos Farmacêuticos S.A Market Cap History: 2015 to 2026
Profarma Distribuidora de Produtos Farmacêuticos S.A's market capitalization history from 2015 to 2026. Data shows growth from $88.91 Million to $170.57 Million (4.18% CAGR).
Index Memberships
Profarma Distribuidora de Produtos Farmacêuticos S.A is a constituent of 1 market index:
| Index | Total Market Cap | Weight (%) | Rank by Market Cap |
|---|---|---|---|
|
SAO PAULO SE IGCX INDEX
IGCX
|
$600.90 Billion | 0.03% | #93 of 155 |
Weight: Profarma Distribuidora de Produtos Farmacêuticos S.A's market cap as a percentage of total index value. Rank: Position among all constituents by market cap.
Profarma Distribuidora de Produtos Farmacêuticos S.A Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Profarma Distribuidora de Produtos Farmacêuticos S.A's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
0.02x
Profarma Distribuidora de Produtos Farmacêuticos S.A's market cap is 0.02 times its annual revenue
Latest Price to Earnings (P/E) Ratio
1.36x
Profarma Distribuidora de Produtos Farmacêuticos S.A's market cap is 1.36 times its annual earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2015 | $88.91 Million | $3.47 Billion | -$21.18 Million | 0.03x | N/A |
| 2016 | $151.86 Million | $4.08 Billion | -$48.96 Million | 0.04x | N/A |
| 2017 | $138.02 Million | $4.10 Billion | -$112.72 Million | 0.03x | N/A |
| 2018 | $76.10 Million | $4.27 Billion | -$9.73 Million | 0.02x | N/A |
| 2019 | $125.28 Million | $4.80 Billion | $11.98 Million | 0.03x | 10.46x |
| 2020 | $118.12 Million | $5.48 Billion | $52.33 Million | 0.02x | 2.26x |
| 2021 | $120.52 Million | $6.41 Billion | $78.19 Million | 0.02x | 1.54x |
| 2022 | $78.98 Million | $7.82 Billion | $80.87 Million | 0.01x | 0.98x |
| 2023 | $140.97 Million | $8.66 Billion | $70.40 Million | 0.02x | 2.00x |
| 2024 | $156.14 Million | $10.15 Billion | $114.58 Million | 0.02x | 1.36x |
Competitor Companies of PFRM3 by Market Capitalization
Companies near Profarma Distribuidora de Produtos Farmacêuticos S.A in the global market cap rankings as of August 6, 2026.
Key companies related to Profarma Distribuidora de Produtos Farmacêuticos S.A by market ranking:
- McKesson Corporation (NYSE:MCK): Ranked #275 globally with a market cap of $94.62 Billion USD.
- Cencora Inc. (NYSE:COR): Ranked #531 globally with a market cap of $50.53 Billion USD.
- Cardinal Health Inc (NYSE:CAH): Ranked #632 globally with a market cap of $43.01 Billion USD.
- Sigma Healthcare Ltd (AU:SIG): Ranked #1091 globally with a market cap of $24.34 Billion USD ( AU$34.40 Billion AUD).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #275 | McKesson Corporation | NYSE:MCK | $94.62 Billion | $877.23 |
| #531 | Cencora Inc. | NYSE:COR | $50.53 Billion | $317.22 |
| #632 | Cardinal Health Inc | NYSE:CAH | $43.01 Billion | $239.23 |
| #1091 | Sigma Healthcare Ltd | AU:SIG | $24.34 Billion | AU$2.98 |
Profarma Distribuidora de Produtos Farmacêuticos S.A Historical Marketcap From 2015 to 2026
Between 2015 and today, Profarma Distribuidora de Produtos Farmacêuticos S.A's market cap moved from $88.91 Million to $ 170.57 Million, with a yearly change of 4.18%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | R$170.57 Million | -22.34% |
| 2025 | R$219.65 Million | +40.68% |
| 2024 | R$156.14 Million | +10.76% |
| 2023 | R$140.97 Million | +78.48% |
| 2022 | R$78.98 Million | -34.47% |
| 2021 | R$120.52 Million | +2.03% |
| 2020 | R$118.12 Million | -5.72% |
| 2019 | R$125.28 Million | +64.63% |
| 2018 | R$76.10 Million | -44.86% |
| 2017 | R$138.02 Million | -9.12% |
| 2016 | R$151.86 Million | +70.81% |
| 2015 | R$88.91 Million | -- |
End of Day Market Cap According to Different Sources
On Aug 6th, 2026 the market cap of Profarma Distribuidora de Produtos Farmacêuticos S.A was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $170.57 Million USD |
| MoneyControl | $170.57 Million USD |
| MarketWatch | $170.57 Million USD |
| marketcap.company | $170.57 Million USD |
| Reuters | $170.57 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Profarma Distribuidora de Produtos Farmacêuticos S.A
Profarma Distribuidora de Produtos Farmacêuticos S.A., together with its subsidiaries, engages in the distribution of pharmaceutical products in Brazil. It provides pharmaceutical, personal hygiene, and beauty products. The company operates retail stores under the Drogasmil, Farmalife, Drogarias Tamoio and Drogaria Rosário brands. Profarma Distribuidora de Produtos Farmacêuticos S.A. was incorpor… Read more